Diagnosis reagent for primary hepatocellular carcinoma, reagent kit and prevention and cure medicaments
A hepatocellular carcinoma, primary technology, applied in the direction of drug combination, gene therapy, anti-tumor drugs, etc., can solve the problems of difficult diagnosis, early diagnosis and prevention of hepatocellular carcinoma, improve survival rate and broad application prospects Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Example 1 Preliminary determination of the relationship between human phosphoglycerate mutase 1 and the occurrence and development of primary hepatocellular carcinoma
[0042] 1. Cell source and culture conditions
[0043] Human liver cancer cell line HepG2 was purchased from ATCC (American Type Culture Collection), and human normal liver cell line L02 was purchased from China Cell Culture Center.
[0044] HepG2 was cultured in DMEM, wherein 10% fetal bovine serum, 10 7 U / L penicillin and 10mg / L streptomycin, while L02 was cultured in RPMI 1640. The culture conditions were all 37°C, 5% CO 2 concentration.
[0045] 2. Reagent source
[0046] Cell culture stable isotope labeling technology (SILAC) related reagents: fetal bovine serum was purchased from Hyclone Company;
[0047] SDS-PAGE related reagents: DC protein assay kit was purchased from Bio-Rad; Coomassie Brilliant Blue R-250 was purchased from Merck;
[0048] Reagents related to enzymatic hydrolysis and mass s...
Embodiment 2
[0080] Example 2 Verification that phosphoglycerate mutase 1 is a protein related to the occurrence and development of primary hepatocellular carcinoma
[0081] RT-PCR and Western Blot were used to verify the expression difference of human phosphoglycerate mutase 1 between primary hepatocellular carcinoma and normal liver tissue at the transcriptional and translational levels.
[0082] 1. Sources of primary hepatocellular carcinoma and normal liver tissue samples
[0083] The tissue samples of 54 cases of primary hepatocellular carcinoma selected in this example were collected from patients with primary hepatocellular carcinoma undergoing surgery in the Department of Hepatobiliary Surgery, West China Hospital, Sichuan University, from April to June 2007. The age distribution of the patients ranged from 34 to 66 years old, with an average age of 44.8±8.5 years old. All patients had not received chemotherapy or radiotherapy before operation. The postoperative pathological diagno...
Embodiment 3
[0128] Example 3 Immunohistochemical analysis of the expression of human phosphoglycerate mutase 1 in primary hepatocellular carcinoma and normal liver tissue
[0129] 1. Tissue sample source
[0130] Paraffin specimens were obtained from the Department of Hepatobiliary Surgery, West China Hospital, Sichuan University. The relevant information of 54 cases of primary hepatocellular carcinoma tissue samples and 21 cases of normal liver tissue samples has been described in Example 2.
[0131] 2. Reagent source
[0132] EnVision + horseradish peroxidase (HRP) immunohistochemical staining system was purchased from Dako Cytomation GmbH in Hamburg, Germany, which included peroxidase blocking solution (Peroxidase Block), horseradish peroxidase-labeled polymer conjugated sheep antibody Rabbit IgG (Labelled Polymer-HRP ANTI-RABBIT), substrate buffer (Substrate Buffer), DAB staining solution (DAB+Chromogen). Goat anti-human phosphoglycerate mutase 1 antibody was purchased from Abcam. ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com